Abstract LB-068: From intracellular antibody fragments to small molecule inhibitors of mutant KRAS

Abstract LB-068: From intracellular antibody fragments to small molecule inhibitors of mutant KRAS

書目詳細資料
Main Authors:	Quevedo, C, Cruz, A, Tulmin, H, Bataille, C, Tanaka, T, Petch, D, Russell, A, Phillips, S, Rabbitts, T
格式:	Journal article
語言:	English
出版:	American Association for Cancer Research 2017

相似書籍

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
由: Quevedo, C, et al.
出版: (2018)

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
由: Bery, N, et al.
出版: (2018)

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
由: Nicolas Bery, et al.
出版: (2020-06-01)

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
由: Ke Xu, et al.
出版: (2019-04-01)

Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.
由: Tanaka, T, et al.
出版: (2010)

Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds.
由: Tanaka, T, et al.
出版: (2008)

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
由: Nicolas Bery, et al.
出版: (2018-07-01)

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
由: Nicolas Bery, et al.
出版: (2018-08-01)

Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies.
由: Tanaka, T, et al.
出版: (2003)

P068: Withdrawn
出版: (2024-01-01)

Abstract 068: Basilar artery bifurcation anatomy as a determinant of recanalization and stroke outcome
由: Mohammad Hossein Abbasi, et al.
出版: (2023-11-01)

Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules.
由: Lobato, M, et al.
出版: (2004)

The selection of single-domain antibody fragments (iDAbs) by intracellular antibody capture in yeast
由: Rabbitts, T, et al.
出版: (2018)

A pan-KRAS degrader for the treatment of KRAS-mutant cancers
由: Jie Yang, et al.
出版: (2024-06-01)

Isolation of antigen-specific intracellular antibody fragments as single chain Fv for use in mammalian cells.
由: Tse, E, et al.
出版: (2002)

Intracellular antibody capture (IAC) methods for single domain antibodies.
由: Tanaka, T, et al.
出版: (2012)

Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
由: Satoru Miyazaki, et al.
出版: (2025-02-01)

A 0.68V 0.68mW 2.4GHz PLL for ultra-low power RF systems
由: Paidimarri, Arun, et al.
出版: (2015)

Role of silent mutations in KRAS-mutant tumors
由: Jun Lu, et al.
出版: (2025-02-01)

Small molecular inhibitors for KRAS-mutant cancers
由: Xuan Wu, et al.
出版: (2023-08-01)

Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization
由: Kohei Maruyama, et al.
出版: (2025-01-01)

Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
由: Liu X, et al.
出版: (2019-08-01)

Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation.
由: Tanaka, T, et al.
出版: (2003)

LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion
由: Marazioti, A, et al.
出版: (2016)

A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins
由: Nicolas Bery, et al.
出版: (2022-02-01)

Exploring KRas Protein Dynamics: An Integrated Molecular Dynamics Analysis of KRas Wild and Mutant Variants
由: Showkat Ahmad Mir, et al.
出版: (2024-07-01)

Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
由: Pérez-Martínez, D, et al.
出版: (2010)

5.068 Physical Methods in Inorganic Chemistry, Spring 2005
由: Mueller, Peter
出版: (2005)

P.068 ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH SCLERODERMIA
由: M. Bernardini*, et al.
出版: (2007-06-01)

Mutant KRAS promotes malignant pleural effusion formation
由: Αgalioti, T, et al.
出版: (2017)

Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.
由: Tanaka, T, et al.
出版: (2011)

Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein
由: Bao, L, et al.
出版: (2017)

Structural modifications and kinetic effects of KRAS interactions with HRAS and NRAS: an in silico comparative analysis of KRAS mutants
由: Isaac Silverman, et al.
出版: (2024-08-01)

068 POST PARTUM MAGNESIUM TOXICITY IN PATIENT WITH CHRONIC KIDNEY DISEASE
由: Nabilah Che Arbaei, et al.
出版: (2017-08-01)

Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein.
由: Tse, E, et al.
出版: (2002)

Research progress in the related treatment of KRAS mutant colorectal cancer
由: ZHANG Shaohua, LI Zhening, WANG Wei, WEI Yifan, HONG Yonggang, HAO Liqiang
出版: (2024-10-01)

Oncogenic mutant KRAS inhibition through oxidation at cysteine 118
由: Maximilian Kramer‐Drauberg, et al.
出版: (2025-02-01)

Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors
由: Patrícia Dias Carvalho, et al.
出版: (2022-06-01)

Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy.
由: Xin Dai, et al.
出版: (2015-01-01)

Mutant KRAS Exosomes Influence the Metabolic State of the Colon Microenvironment
由: Ranjan Preet, PhD, et al.
出版: (2018-01-01)